FDA Approved: COMBIVENT RESPIMAT — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Combivent Respimat (ipratropium bromide and albuterol) in an original application for relief of bronchospasm associated with chronic obstructive pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• Combivent Respimat (ipratropium bromide and albuterol sulfate)

Snippet

ORIG AP for COMBIVENT RESPIMAT (IPRATROPIUM BROMIDE AND ALBUTEROL)